封面
市場調查報告書
商品編碼
1682190

2025年COVID-19抗原檢測全球市場報告

COVID-19 Antigen Test Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年 COVID-19 抗原檢測市場規模將出現強勁成長。到 2029 年,這一數字將成長至 101.9 億美元,年複合成長率(CAGR)為 7.4%。預測期內的成長可歸因於就地檢驗的擴展、新型冠狀病毒監測、公共衛生措施、市場競爭、新病毒株和持續的威脅。預測期內的關鍵趨勢包括下一代抗原檢測的開發和核准、數位和智慧型手機技術的整合以報告檢測結果、高風險環境中檢測基礎設施的擴展、對家庭抗原檢測套組的需求增加、關注經濟實惠且易於獲取的檢測解決方案,以及對變體特異性抗原檢測的持續研究。

隨著自行管理的檢測套組的普及度預計將激增,COVID-19 抗原檢測市場預計未來將會成長。自行管理的檢測套組是專為個人在家中自行使用的診斷工具,無需醫療專業人員或訓練有素的負責人。自行管理的檢測套組的廣泛普及將有助於 COVID-19 抗原檢測的廣泛普及,有助於減緩病毒的傳播,並允許人們在舒適的家中識別感染。根據美國疾病管制與預防中心 2022 年美國的數據,從Delta主導時期(2021 年 8 月至 12 月)到 Omicron 主導時期(2022 年 12 月至 3 月),美國18 歲及以上成年人使用家庭檢測 COVID-19 的情況顯著增加。在出現 COVID-19 症狀的受訪者中,接受家庭檢測的比例從 5.7% 上升至 20.1%。因此,自我檢測套組的普及正在推動 COVID-19 抗原檢測市場的成長。

預計未來幾年檢測率的上升將推動 COVID-19 抗原檢測市場的成長。檢測率是指在特定人群或特定時間內進行診斷測試(例如 COVID-19 測試)的頻率。隨著檢測率的提高,對 COVID-19 檢測解決方案(包括抗原檢測)的需求不斷成長。需求的成長直接促進了市場的擴大,迫使製造商和供應商生產和銷售更多的測試以滿足日益成長的需求。根據美國國立衛生研究院 2023 年 10 月的數據,2022 年 10 月至 2023 年 10 月的 COVID-19 總檢測率為每 1,000 人 5.13 至 22,386.63 人次。因此,提高檢測率是 COVID-19 抗原檢測市場成長的主要驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場-宏觀經濟情景,包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球COVID-19抗原檢測PESTEL分析(政治、社會、技術、環境、法律、促進因素、限制因素)
  • 最終用途產業分析
  • 全球COVID-19抗原檢測市場:成長率分析
  • 全球 COVID-19 抗原檢測市場表現:規模與成長,2019-2024 年
  • 全球 COVID-19 抗原檢測市場預測:規模與成長,2024-2029 年,2034 年
  • 全球 COVID-19 抗原檢測總目標市場 (TAM)

第6章市場區隔

  • 全球 COVID-19 抗原檢測市場(依產品與服務、績效及預測)2019-2024 年、2024-2029 年、2034 年
  • 平台
  • 試劑和套件
  • 服務
  • 全球 COVID-19 抗原檢測市場(按樣本類型、表現和預測),2019-2024 年、2024-2029 年、2034 年
  • 鼻咽拭子
  • 口咽拭子
  • 鼻拭子
  • 全球 COVID-19 抗原檢測市場(按最終用途、性能和預測),2019-2024 年、2024-2029 年、2034 年
  • 診所和醫院
  • 居家護理
  • 診斷實驗室
  • 其他用途
  • 全球 COVID-19 抗原檢測市場細分(按平台、類型、績效及預測),2019-2024 年、2024-2029 年、2034 年
  • 橫向流動平台
  • ELISA平台
  • 其他平台
  • 全球 COVID-19 抗原檢測市場,按試劑和套件類型細分,性能和預測,2019-2024 年、2024-2029 年、2034 年
  • 檢測套組
  • 試劑
  • 全球 COVID-19 抗原檢測市場,依服務類型、績效及預測細分,2019-2024 年、2024-2029 年、2034 年
  • 測試服務
  • 化驗服務

第7章 區域和國家分析

  • 全球 COVID-19 抗原檢測市場:按地區、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球 COVID-19 抗原檢測市場:按國家、表現和預測,2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章競爭格局與公司概況

  • COVID-19 抗原檢測市場:競爭格局
  • COVID-19抗原檢測市場:公司簡介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Becton And Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation Of America Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Quidel Corporation
  • SD Biosensor Inc.
  • Diasorin SPA
  • Biosynex Swiss SA
  • iHealth Labs Inc.
  • Everlywell Inc.
  • JOYSBIO Biotechnology Co. Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • Access Bio Inc.
  • RayBiotech Life Inc.
  • CTK Biotech Inc.
  • Artron Laboratories Inc.
  • Princeton BioMeditech Corporation
  • ACON Laboratories Inc.
  • BioLytical Laboratories Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年 COVID-19 抗原檢測市場:提供新機會的國家
  • 2029 年 COVID-19 抗原檢測市場:細分市場帶來新機會
  • 2029 年 COVID-19 抗原檢測市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r27797

COVID-19 is an infectious respiratory illness caused by the Severe Acute Respiratory Syndrome COVID-19 2 (SARS-CoV-2), affecting the human respiratory system and resulting in infections ranging from the common cold to more severe respiratory diseases. The COVID-19 antigen test serves as a diagnostic tool to identify the presence of specific proteins from the SARS-CoV-2 virus in a person's respiratory specimen. This test typically employs a sample collected from a nasal or throat swab.

The primary products and services associated with COVID-19 antigen tests include platforms, reagents and kits, and various services. Platforms refer to specific technologies or systems utilized for conducting particular tests. Nasopharyngeal swabs, oropharyngeal swabs, and nasal swab specimens are commonly used by clinics, hospitals, home care services, diagnostic labs, and other end-users in the process of conducting COVID-19 antigen tests.

The COVID-19 antigen testsCOVID-19 antigen tests market research report is one of a series of new reports from The Business Research Company that provides COVID-19 antigen testsCOVID-19 antigen tests market statistics, including COVID-19 antigen testsCOVID-19 antigen tests industry global market size, regional shares, competitors with a COVID-19 antigen testsCOVID-19 antigen tests market share, detailed COVID-19 antigen testsCOVID-19 antigen tests market segments, market trends and opportunities, and any further data you may need to thrive in the COVID-19 antigen testsCOVID-19 antigen tests industry. This COVID-19 antigen testsCOVID-19 antigen tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The COVID-19 antigen test market size has grown strongly in recent years. It will grow from $7.13 billion in 2024 to $7.65 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to pandemic outbreak, emergency regulatory approvals, supply chain challenges, government initiatives, global vaccination efforts.

The COVID-19 antigen test market size is expected to see strong growth in the next few years. It will grow to $10.19 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to point-of-care testing expansion, new variants surveillance, public health measures, market competition, emerging variants and continued threat. Major trends in the forecast period include development and approval of next-generation antigen tests, integration of digital and smartphone technologies for test result reporting, expansion of testing infrastructure in high-risk settings, increasing demand for home-based antigen test kits, emphasis on affordable and accessible testing solutions, continuous research for variants-specific antigen tests.

The anticipated surge in popularity of self-administered test kits is expected to drive the growth of the COVID-19 antigen test market in the future. Self-administered test kits are diagnostic tools designed for individuals to use on themselves at home, eliminating the need for medical professionals or trained personnel. The increased adoption of self-administered test kits contributes to the wider availability of COVID-19 antigen tests, aiding in slowing the spread of the virus and enabling individuals to identify infections in the comfort of their homes. According to the Centers for Disease Control and Prevention in April 2022, there was a significant rise in the use of at-home COVID-19 tests among U.S. adults aged 18 and older during the Delta-predominant period (August to December 2021) to the Omicron-predominant period (December to March 2022). The use of at-home tests among respondents with COVID-19-such as symptoms increased from 5.7% to 20.1%. Therefore, the increasing popularity of self-administered test kits is a driving force behind the growth of the COVID-19 antigen test market.

An upsurge in testing rates is anticipated to fuel the growth of the COVID-19 antigen test market in the future. Testing rates represent the frequency of diagnostic tests, such as COVID-19 tests, performed within a given population or over a specific period. As testing rates increase, there is a growing demand for COVID-19 testing solutions, including antigen tests. This heightened demand directly contributes to the market's expansion, requiring manufacturers and suppliers to produce and distribute more tests to meet the rising needs. According to the National Institutes of Health in October 2023, the total COVID-19 testing rate ranged from 5.13 to 22,386.63 per 1000 people from October 2022 to October 2023. Therefore, the increase in testing rates is a key driver of the COVID-19 antigen test market's growth.

In July 2022, Meridian Bioscience Inc., a U.S.-based company, announced a definitive merger agreement with SD Biosensor Inc., located in South Korea, and SJL Partners LLC, also based in Seoul, South Korea. This strategic initiative, spearheaded by a consortium including SD Biosensor and SJL, aims to enhance Meridian's ability to serve its customers as it shifts away from the peak demand for COVID-19 testing. Furthermore, this merger will facilitate the development of new diagnostic products by leveraging SD Biosensor's industry expertise and complementary offerings, thereby expanding the companies' reach and fostering innovation in the diagnostics market.

Major companies operating in the COVID-19 antigen test market report are F. Hoffmann-La Roche AG, Abbott Laboratories, Becton And Dickinson and Company, Laboratory Corporation Of America, PerkinElmer Inc., Quidel Corporation, SD Biosensor Inc., Diasorin S.P.A, Biosynex Swiss SA, iHealth Labs Inc., Everlywell Inc., JOYSBIO Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt. Ltd., Access Bio Inc., RayBiotech Life Inc., CTK Biotech Inc., Artron Laboratories Inc., Princeton BioMeditech Corporation, ACON Laboratories Inc., BioLytical Laboratories Inc., BioNote Inc., Assure Tech (Hangzhou) Co. Ltd., ADS biotech Inc., ANP Technologies Inc., BTNX Inc., Cellspect Co.Ltd., Empowered Diagnostics LLC, GenBody Inc., Beijing Wantai Biologicalpharmacy Enterprise Co. Ltd.

Asia-Pacific was the largest region in the COVID-19 antigen test market in 2024. The regions covered in the COVID-19 antigen test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the COVID-19 antigen test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The COVID-19 antigen test market consists of revenues earned by entities by providing services such as point-of-care testing (POC), telehealth services, travel testing services, and healthcare provider testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 antigen test market also includes sales of sample collection devices, extraction kits, buffers and solutions, and control materials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

COVID-19 Antigen Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on covid-19 antigen test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for covid-19 antigen test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The covid-19 antigen test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Platforms; Reagents And Kits; Services
  • 2) By Specimen Type: Nasopharyngeal Swab; Oropharyngeal Swab; Nasal Swab
  • 3) By End-Use: Clinics And Hospitals; Home Care; Diagnostic Labs; Other End-Uses
  • Subsegments:
  • 1) By Platforms: Lateral Flow Platforms; ELISA Platforms; Other Platforms
  • 2) By Reagents And Kits: Test Kits; Reagents
  • 3) By Services: Testing Services; Laboratory Services
  • Companies Mentioned: F. Hoffmann-La Roche AG; Abbott Laboratories; Becton And Dickinson and Company; Laboratory Corporation Of America; PerkinElmer Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. COVID-19 Antigen Test Market Characteristics

3. COVID-19 Antigen Test Market Trends And Strategies

4. COVID-19 Antigen Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global COVID-19 Antigen Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global COVID-19 Antigen Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global COVID-19 Antigen Test Market Growth Rate Analysis
  • 5.4. Global COVID-19 Antigen Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global COVID-19 Antigen Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global COVID-19 Antigen Test Total Addressable Market (TAM)

6. COVID-19 Antigen Test Market Segmentation

  • 6.1. Global COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Platforms
  • Reagents And Kits
  • Services
  • 6.2. Global COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasopharyngeal Swab
  • Oropharyngeal Swab
  • Nasal Swab
  • 6.3. Global COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinics And Hospitals
  • Home Care
  • Diagnostic Labs
  • Other End-Uses
  • 6.4. Global COVID-19 Antigen Test Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lateral Flow Platforms
  • ELISA Platforms
  • Other Platforms
  • 6.5. Global COVID-19 Antigen Test Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Test Kits
  • Reagents
  • 6.6. Global COVID-19 Antigen Test Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Testing Services
  • Laboratory Services

7. COVID-19 Antigen Test Market Regional And Country Analysis

  • 7.1. Global COVID-19 Antigen Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global COVID-19 Antigen Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific COVID-19 Antigen Test Market

  • 8.1. Asia-Pacific COVID-19 Antigen Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China COVID-19 Antigen Test Market

  • 9.1. China COVID-19 Antigen Test Market Overview
  • 9.2. China COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India COVID-19 Antigen Test Market

  • 10.1. India COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan COVID-19 Antigen Test Market

  • 11.1. Japan COVID-19 Antigen Test Market Overview
  • 11.2. Japan COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia COVID-19 Antigen Test Market

  • 12.1. Australia COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia COVID-19 Antigen Test Market

  • 13.1. Indonesia COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea COVID-19 Antigen Test Market

  • 14.1. South Korea COVID-19 Antigen Test Market Overview
  • 14.2. South Korea COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe COVID-19 Antigen Test Market

  • 15.1. Western Europe COVID-19 Antigen Test Market Overview
  • 15.2. Western Europe COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK COVID-19 Antigen Test Market

  • 16.1. UK COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany COVID-19 Antigen Test Market

  • 17.1. Germany COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France COVID-19 Antigen Test Market

  • 18.1. France COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy COVID-19 Antigen Test Market

  • 19.1. Italy COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain COVID-19 Antigen Test Market

  • 20.1. Spain COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe COVID-19 Antigen Test Market

  • 21.1. Eastern Europe COVID-19 Antigen Test Market Overview
  • 21.2. Eastern Europe COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia COVID-19 Antigen Test Market

  • 22.1. Russia COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America COVID-19 Antigen Test Market

  • 23.1. North America COVID-19 Antigen Test Market Overview
  • 23.2. North America COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA COVID-19 Antigen Test Market

  • 24.1. USA COVID-19 Antigen Test Market Overview
  • 24.2. USA COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada COVID-19 Antigen Test Market

  • 25.1. Canada COVID-19 Antigen Test Market Overview
  • 25.2. Canada COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America COVID-19 Antigen Test Market

  • 26.1. South America COVID-19 Antigen Test Market Overview
  • 26.2. South America COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil COVID-19 Antigen Test Market

  • 27.1. Brazil COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East COVID-19 Antigen Test Market

  • 28.1. Middle East COVID-19 Antigen Test Market Overview
  • 28.2. Middle East COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa COVID-19 Antigen Test Market

  • 29.1. Africa COVID-19 Antigen Test Market Overview
  • 29.2. Africa COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. COVID-19 Antigen Test Market Competitive Landscape And Company Profiles

  • 30.1. COVID-19 Antigen Test Market Competitive Landscape
  • 30.2. COVID-19 Antigen Test Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton And Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Laboratory Corporation Of America Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. COVID-19 Antigen Test Market Other Major And Innovative Companies

  • 31.1. Quidel Corporation
  • 31.2. SD Biosensor Inc.
  • 31.3. Diasorin S.P.A
  • 31.4. Biosynex Swiss SA
  • 31.5. iHealth Labs Inc.
  • 31.6. Everlywell Inc.
  • 31.7. JOYSBIO Biotechnology Co. Ltd.
  • 31.8. Mylab Discovery Solutions Pvt. Ltd.
  • 31.9. Access Bio Inc.
  • 31.10. RayBiotech Life Inc.
  • 31.11. CTK Biotech Inc.
  • 31.12. Artron Laboratories Inc.
  • 31.13. Princeton BioMeditech Corporation
  • 31.14. ACON Laboratories Inc.
  • 31.15. BioLytical Laboratories Inc.

32. Global COVID-19 Antigen Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The COVID-19 Antigen Test Market

34. Recent Developments In The COVID-19 Antigen Test Market

35. COVID-19 Antigen Test Market High Potential Countries, Segments and Strategies

  • 35.1 COVID-19 Antigen Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 COVID-19 Antigen Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 COVID-19 Antigen Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer